Johnson & Johnson vs Merck & Co
Johnson & Johnson (JNJ), health care, and Merck & Co (MRK), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.
Johnson & Johnson is worth $675.5B on the stock market and Merck & Co $354.4B: Johnson & Johnson is valued at 91% more. Johnson & Johnson trades at 42.6 times earnings and Merck & Co at 145. Over the past year Johnson & Johnson's share price has moved +41.3% and Merck & Co's +49.8%.
Key facts
- Johnson & Johnson market value
- $675.5B
- Merck & Co market value
- $354.4B
- Johnson & Johnson P/E
- 42.6
- Merck & Co P/E
- 145
- Johnson & Johnson revenue
- $94.2BFY to 2025-12-28
- Merck & Co revenue
- $65BFY to 2025-12-31
- Superinvestors holding both
- 13
Market values as of .
| Measure | Johnson & Johnson | Merck & Co |
|---|---|---|
| Sector | Health Care | Health Care |
| Country | ||
| Fiscal year ends | 2025-12-28 | 2025-12-31 |
| Size | ||
| Market cap | $675.5Bhigher | $354.4Blower |
| Revenue | $94.2Bhigher | $65Blower |
| Earnings | $26.8Bhigher | $18.3Blower |
| Employees | 138,200higher | 73,000lower |
| Total assets | $199.2Bhigher | $136.9Blower |
| Valuation | ||
| P/E | 42.6lower | 145higher |
| P/S | 7.2higher | 5.5lower |
| P/B | 8.3higher | 7.9lower |
| Dividend yield | 1.87%lower | 2.33%higher |
| Profitability | ||
| Operating margin | — | — |
| Balance sheet | ||
| Net assets | $81.5Bhigher | $52.6Blower |
| Total liabilities | $117.7Bhigher | $84.2Blower |
| Total debt | $47.9Blower | $49.3Bhigher |
| Cash on hand | $19.7Bhigher | $14.6Blower |
| Price change | ||
| Today | -0.68%lower | -0.48%higher |
| 1 year | +41.3%lower | +49.8%higher |
Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.
Which superinvestors hold them
From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.
Both (13)
- Jeremy Grantham (co-founder)4.0% / 1.6%
- Mark Boyar2.6% / 0.5%
- Ken Fisher1.1% / 1.7%
- Mairs & Power team0.9% / 0.1%
- Charles Brandes (founder)0.3% / 1.5%
- Cliff Asness0.3% / 0.4%
- Ken Griffin0.2% / 0.1%
- Murray Stahl0.1% / 0.1%
- Christopher Bloomstran<0.1% / 0.6%
- Howard Gleicher<0.1% / 2.0%
- Rajiv Jain<0.1% / <0.1%
- Dodge & Cox team<0.1% / <0.1%
- Thomas Russo<0.1% / <0.1%
Johnson & Johnson only (10)
- Tweedy, Browne team4.1%
- Stephen Yacktman4.0%
- Tom Gayner1.3%
- Fred DiSanto1.1%
- Ray Dalio (founder)0.7%
- Andrew Spokes0.7%
- Mario Gabelli0.2%
- George Soros0.1%
- Jensen team0.1%
- John Rogers0.1%
Merck & Co only (10)
- Bill Smead7.1%
- Thomas Kahn4.9%
- Bill Nygren2.1%
- Josef Lakonishok1.4%
- Prem Watsa0.9%
- Sarah Ketterer0.6%
- Temasek0.3%
- David Shaw (founder)0.2%
- Brandon Haley0.2%
- Joel Greenblatt0.2%
Percentages are each holding's share of that investor's reported portfolio (under "Both": Johnson & Johnson / Merck & Co). Who owns JNJ · Who owns MRK
More on Johnson & Johnson
Further comparisons
Johnson & Johnson against its closest peers
Merck & Co against its closest peers
Learn
Questions and answers
Which is bigger, Johnson & Johnson or Merck & Co?
By market value, Johnson & Johnson is the larger: $675.5B against $354.4B for Merck & Co. By revenue in its latest fiscal year, Johnson & Johnson is the larger: $94.2B against $65B for Merck & Co.
Which has the higher P/E ratio?
Merck & Co: 145, against 42.6 for Johnson & Johnson. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.
Which has the higher dividend yield?
Merck & Co: 2.33%, against 1.87% for Johnson & Johnson. Dividend yield is the last twelve months' dividends as a share of today's share price.
Which has more debt?
Merck & Co: $49.3B, against $47.9B for Johnson & Johnson. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.
Which superinvestors own both Johnson & Johnson and Merck & Co?
In their latest 13F filings, Jeremy Grantham (co-founder), Mark Boyar, Ken Fisher, Mairs & Power team, Charles Brandes (founder), Cliff Asness, Ken Griffin, Murray Stahl, Christopher Bloomstran, Howard Gleicher, Rajiv Jain, Dodge & Cox team and Thomas Russo hold both.
Cite this page
Funkfolio, “Johnson & Johnson vs Merck & Co”, data as of 17 November 2026. https://funkfolio.com/compare/jnj-vs-mrk
Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.